We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

105 hedge funds and large institutions have $355M invested in GenMark Diagnostics, Inc in 2018 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 24 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 9

54% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 24

16% more capital invested

Capital invested by funds: $306M → $355M (+$48.7M)

7% more funds holding

Funds holding: 98 → 105 (+7)

Holders
105
Holders Change
+7
Holders Change %
+7.14%
% of All Funds
2.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
37
Reduced
24
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$4.5M
2
BlackRock
BlackRock
New York
+$1.65M
3
State Street
State Street
Massachusetts
+$1.25M
4
Morgan Stanley
Morgan Stanley
New York
+$1.19M
5
KCM
Kennedy Capital Management
Missouri
+$1.16M

Top Sellers

Rank Fund Capital Flow
1
PI
Putnam Investments
Massachusetts
-$4.69M
2
CCM
Cadian Capital Management
New York
-$3.71M
3
JP Morgan Chase
JP Morgan Chase
New York
-$3.47M
4
CC
Casdin Capital
New York
-$2.97M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$1.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
26
Federated Hermes
Pennsylvania
$1.28M – – –
KCM
27
Kennedy Capital Management
Missouri
$1.25M +$1.16M +175,696 +897%
Two Sigma Investments
28
Two Sigma Investments
New York
$1.18M +$474K +71,661 +63%
TD Asset Management
29
TD Asset Management
Ontario, Canada
$1.16M +$15.9K +2,400 +1%
BCM
30
Bridgeway Capital Management
Texas
$1.15M – – –
Jacobs Levy Equity Management
31
Jacobs Levy Equity Management
New Jersey
$1.1M -$254K -38,417 -18%
Russell Investments Group
32
Russell Investments Group
United Kingdom
$1.1M +$110K +16,611 +11%
WMSA
33
Weiss Multi-Strategy Advisers
New York
$1.08M -$198K -30,000 -15%
TCIM
34
TIAA CREF Investment Management
New York
$1.03M -$34.7K -5,256 -3%
Two Sigma Advisers
35
Two Sigma Advisers
New York
$930K +$197K +29,800 +26%
TA
36
Teachers Advisors
New York
$818K +$22.6K +3,424 +3%
Citadel Advisors
37
Citadel Advisors
Florida
$808K +$403K +60,991 +93%
Jennison Associates
38
Jennison Associates
New York
$676K -$570K -86,248 -45%
Deutsche Bank
39
Deutsche Bank
Germany
$664K +$208K +31,448 +43%
BFS
40
Bradley Foster & Sargent
Connecticut
$651K +$674K +102,015 New
GIP
41
Granite Investment Partners
California
$642K -$796K -120,361 -54%
William Blair & Company
42
William Blair & Company
Illinois
$614K – – –
Swiss National Bank
43
Swiss National Bank
Switzerland
$568K – – –
RA
44
Royce & Associates
New York
$566K -$97.2K -14,700 -14%
DCM
45
Donaldson Capital Management
Indiana
$530K +$99.6K +15,075 +22%
Goldman Sachs
46
Goldman Sachs
New York
$513K +$303K +45,802 +132%
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$503K – – –
UBS AM
48
UBS AM
Illinois
$436K +$125K +18,887 +38%
ARTA
49
A.R.T. Advisors
New York
$423K -$422K -63,901 -49%
AllianceBernstein
50
AllianceBernstein
Tennessee
$356K +$43K +6,500 +13%
1
2
3 4 5

GNMK Hedge Fund Activity: Q2 2018 in Review

105 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q2 2018, worth a combined $355M — up 16% from $306M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new GNMK positions and 9 closed out — a net gain of 7 holders — while 37 added to existing stakes and 24 trimmed.

The largest buyer was Millennium Management, adding an estimated $4.5M. The largest seller was Putnam Investments, cutting an estimated $4.69M.

  • 105 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q2 2018, up from 98 in Q1 2018.
  • Funds reported $355M of GenMark Diagnostics, Inc stock for Q2 2018, up 16% quarter-over-quarter.
  • 16 funds opened new GenMark Diagnostics, Inc positions in Q2 2018 and 9 closed out, a net change of +7 holders.
  • The largest GenMark Diagnostics, Inc buyer in Q2 2018 was Millennium Management, an estimated $4.5M added.
  • The largest GenMark Diagnostics, Inc seller in Q2 2018 was Putnam Investments, an estimated $4.69M sold.

Based on aggregated 13F filings for Q2 2018.